Word

Status

Dead

Status Code

710

Status Date

Saturday, May 16, 2009

Serial Number

76075378

Registration Number

2623068

Registration Date

Tuesday, September 24, 2002

Mark Type

2000

Filing Date

Friday, June 16, 2000

Published for Opposition

Tuesday, July 2, 2002

Cancellation Date

Saturday, May 16, 2009

Trademark Owner History

MERISTEM THERAPEUTICS - Original Registrant

Classifications

1 Chemicals for use in the manufacture of photographic materials, namely, paints, wetting agents, fixing agents, developing agents, and stabilizers; chemicals for use in the manufacture of paints, dyes, colorings, cosmetics, glues, and surfactants; chemicals for use in the manufacture of horticultural materials, namely, soil preparation agents and fertilizers; chemicals for use in the manufacture of hormones, peptides, enzymes, proteins in the nature of growth hormones for plants, animals and microbes and growth inhibitors and regulators; chemicals for use in the manufacture of diagnostic reagents, cell culture media, cell regulatory agents, amino acids, DNA fragments, RNA fragments, DNA probes, RNA probes, genetic cloning materials, and genetic expression amplifiers

3 Proteins for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, collagen, serum albumin, RNA, DNA and their extracts, amino acids, ribosomes, ceramides, immunostimulating or in imunoregulatory hormones, all obtained from plants; and enzymes for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, proteases, hydrolases, lipases, deshydroxylases and cellulases, all obtained from plants

5 Pharmaceutical preparations for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; veterinary preparations for the treatment of rabies, obesity, auto-immune diseases, namely, feline immunodeficiency virus and simian immunodeficiency virus, in livestock, domestic pets and wild animals, namely foxes and rodents; acaricides, algaecides, biopesticides, herbicides, insecticides, miticides, pesticides and weed killers for agricultural, domestic or commercial use; pharmaceutical preparations produced from plants or containing proteins produced from plants, for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; therapeutic proteins, hormones, peptides and their complexes, derivatives and cofactors, namely, human serum albumin, lactoferrin, hemoglobin, collagen and procollagen for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; vaccines including antibodies or glycoproteins, namely, glycoprotein G, lipases, namely, gastric lipase, pancreatic lipase; and medicines and pharmaceutical preparations obtained from genetically modified plants or containing the extracts of genetically modified plants for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies

42 Biological and biotechnological laboratory research services, namely genetic modification of plants and plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, biological and biochemical analysis of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; laboratory research in the field of in-vitro reproduction and regeneration of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; biological laboratory services in the field of in-vitro reproduction and regeneration of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; laboratory research in the area of field and greenhouse reproduction of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; biological laboratory services in the area of field and greenhouse reproduction of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; laboratory research and tests regarding genetically modified plants; laboratory research featuring the expression of therapeutic, cosmetic or nutritional proteins or protein fragments through genetic modification, regeneration, and reproduction of plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings

The mark consists of a stylized design of a leaf with human features.

Trademark Events

May 16, 2009

Cancelled Sec. 8 (6-Yr)

Feb 18, 2009

Review Of Correspondence Complete

Feb 2, 2009

Paper Received

Dec 11, 2007

Case File In Ticrs

Sep 24, 2002

Registered-Principal Register

Jul 2, 2002

Published For Opposition

Jun 12, 2002

Notice Of Publication

Jan 30, 2002

Approved For Pub - Principal Register

Nov 5, 2001

Correspondence Received In Law Office

Jul 5, 2001

Final Refusal Mailed

Feb 23, 2001

Correspondence Received In Law Office

Feb 23, 2001

Sec. 1(B) Claim Deleted

Dec 18, 2000

Non-Final Action Mailed

Nov 17, 2000

Assigned To Examiner